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Abstract
Background: Medication non adherence is a global epidemic perplexing phenomenon that is eminent, but not
insurmountable. Our first objective was to explore whether providing pharmacist’s counseling to cardiac patients
prior to discharge can increase patient’s medication adherence, and our second objective was to assess whether
better medication adherence leads to reduction of hospital readmissions.
Methods: Observational study was conducted among diagnosed cardiac patients using an intervention strategy at
discharge from two hospitals in Israel; The Nazareth and the Haemek hospital. 74 patients were recruited between
January 2010 and January 2011. Two separate groups were selected; intervention group: 33 patients who prior to
discharge received nurse, pharmacist interventions, and control group: 41 patients who had received the nurse and
hospital discharge counseling only.
Results: Regression analysis for examining the first objective reflected significant effect when having a pharmacist
interventions, which explains the increasing 11.6% of the variance in medication adherence, [F change (1,73) =
9.43, p < 0.003]. Stepwise regression analysis for examining the second objective demonstrated that the relation
between medication adherence and readmissions was insignificant [F (1,73) = 9.43, n.s].
Conclusions: While physicians and nurses can have an impact on improving adherence, pharmacists have
demonstrated the ability to inform, problem-solve and provide performance support directly to patients.
Keywords: Pharmacist intervention, Cardiac patients, Medication adherence
Background
What is new?
Medication adherence among patients in Israel is very
low, especially among Cardiac patients.
Pharmacist interventions to cardiac patients prior to
discharge from internal medical departments can
improve medication adherence by improving their
knowledge, and can contribute to improving the effec-
tiveness and benefit from medical treatments, and thus
reducing costs of readmissions.
The term adherence is effectively used interchangeably
with compliance. They both describe the agreement
between the medical regimen prescribed by the treating
physician and actual patient practice. However, adher-
ence implies a more active role of the patient in the
process and indicates a responsibility of both parties to
achieve success, but non-compliance becomes linked
with negative connotations [1], so we steer clear of it.
Plainly, compliance suggests a process in which dutiful
patients passively follow the advice of their physicians.
Adherence, in contrast, better fits how most patients
actively participate in their care and decide for them-
selves when and whether to follow their doctor’sa d v i c e .
The failure to adhere to medication instructions either,
willful or inadvertent especially among elderly is
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tion non-adherence were a disease, it could be termed
an “epidemic [2,3].
Indeed, it is a puzzling phenomenon, with eminent
dreadful consequences onto health system, but insur-
mountable merely by using calculated strategies. With
each passing day, tremendous intentions is being made
to understand the core reasons for non-adherence and
design programs that will tackle these issues [4].
Also, there has been a realization by all concerned sta-
keholders that they have to stop viewing non-adherence
as either ‘my problem’ or ‘their problem’ and treat it as
‘our problem’.
Medication non-adherence is a serious problem facing
the health system in general and the medical staff speci-
fically. It is among the leading causes for hospital read-
missions, and it was documented that non-adherence is
responsible for more than 50% of the readmissions
among cardiac patients [5].
Among chronic illnesses, especially heart diseases,
costs are largely derived from expensive exacerbations
that require emergency visits and hospitalizations [6].
It has been shown that 27% of patients hospitalized
for Heart Failure (HF) were re-hospitalized within 90
days, with most of them as a result of medication or
dietary non-adherence [7].
Nevertheless, adherence is an umbrella term used to
embrace various components involved in the process of
patients taking medication as prescribed [8].
Among the documented reasons for medication non-
adherence are lack of education and forgetfulness [9].
Patients’ report of non-adherence includes that several
changes are made to their usual treatment regimen and
they are suddenly forced to take responsibility for their
own health [10]. Moreover, less than 20-25% of the
respondents reported knowledge about side effects and
required lifestyle changes. Additional risk factors to
such behavior are: the use of large number of prescribed
medications, the use of a large number of daily doses
[11].
Indeed, complexity of medication regimens may
adversely affect adherence and treatment outcome. The
results of several studies have shown that, as medication
regimen complexity increases, adherence declines. Medi-
cation complexity includes items on frequency, special
instructions and behaviors related to medications, and
other difficulties encountered [12-15].
The degree of adherence varies across diseases, but for
many chronic diseases, 40% to 50% of patients do not
persist with initial treatments beyond 12 months
[16-18].
In hypertension and cardiovascular risk management
adherence, rates at one year average about 60%,
undoubtedly contributing to the less than optimal blood
pressure control and less than optimal clinical outcomes
of these patients [19]. In fact, adherence to medical
recommendations is a multifactorial behavior and
requires a multimodel response [20]. Therefore, strate-
gies to encourage adherence must not only address per-
sonal and cognitive factors such as knowledge of the
regimen, belief in benefits of treatment, subjective
norms, and attitudes toward medication-taking behavior,
but also environmental and social factors such as the
interpersonal relationship between the provider and the
patient [20].
As we search for strategies and solutions geared
toward improving patient adherence to prescription
drug therapy, it is imperative to involve pharmacists.
While physicians, nurses and other healthcare profes-
sionals can moderately have an impact on improving
adherence alone, the collaboration of pharmacists, as the
medication experts have demonstrated elevated ability to
inform, problem-solve and provide performance support
directly to and with patients. Since, medication dispen-
sing is the best-known function of the pharmacist, phar-
macists–through counseling, from filling the initial
script to completion, medication therapy management,
disease-state management, and other means–can play a
crucial role in patient care.
There are opportunities in every type of pharmacy
practice to improve patients’ adherence and therapeutic
outcomes, and pharmacists must embrace and act
according to them [21].
In this study we are looking to examine the role of the
pharmacists as healthcare professionals who can
improve adherence, since a few studies have been con-
ducted on evaluating the contribution of pharmacist
medication counseling to patients when discharged from
hospitals. Pharmacists can play a quintessential role in
initiating counseling to patients and in monitoring their
adherence in order to improve their treatment out-
comes. Education and counseling regarding medication
therapy given to patients at discharge has been shown
to affect demand and utilization of health services along
several dimensions.
Globally, pharmacist-based patient education is grow-
ing, in part because pharmacists are appreciated to be
“in a privileged position, with their expertise in pharma-
cological treatment, to provide education, identify medi-
cation adherence issues and counsel the patient” [22]. In
addition, many pharmacists utilize shared databases and
information system capabilities that facilitate the flow of
information and generate improved clinical outcomes
and cost benefits in the management of diseases like
hypertension [23,24], diabetes and cardiovascular disease
[25,26]. In one unique Canadian trial to improve treat-
ment adherence among patients with hypertension,
hypercholesterolemia and heart failure, 824 patients
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munities [27].
The study includes in the control setting (n = 28
pharmacies), and in the intervention setting (n = 26
pharmacies). Patients were followed at 3 month inter-
vals, for an average duration of 269 days. For lipid low-
ering therapy, the intervention was associated with an
increase of 13% in patient adherence (p < 0.005) and for
hypertensive patients, the impact was an additional 8%
adherence. Interestingly, in both control and interven-
tion sites, patients had higher than usually reported
adherence rates [27].
The purpose of our study is to shed light on the
underlying causes and consequences of non-adherence
in general, highlighting the impact of different variables,
such as the demographic characteristics, ethnicity, sex,
age and socioeconomic status, complexity of treatment,
patient self-efficacy, social support, disease knowledge,
treatment alternatives, costs and side effects and disrup-
tion of patients’ life style, and specifically to explore the
strategy whether providing pharmacist counseling to
cardiac patients in Israel, prior to discharge from inter-
nal departments, can contribute to increasing patient’s
medication compliance. Since, cardiac patient’sn o n -
adherence documented high rate of readmissions
exceeds roughly 50% countrywide and their coping skills
to face often-fragile condition aggravate their sufferance
substantially and they are particularly at-risk from drug
non-adherence and potentially jeopardize their health
and longevity. Two essentialt a r g e tg o a l sw e r et a k e ni n
mind for this research: The first objective was to explore
whether providing pharmacist interventions and sup-
ports for patients with heart failure prior to discharge
leads to better medication compliance in comparison to
patients discharged with no such interventions?, and the
second goal was if we have better medication compli-
ance; this aim leads to less readmissions?.
Methods
This observational study was conducted among diag-
nosed Chronic Heart Failure (CHF) patients using a
pharmacists intervention strategy which was operated at
the time of discharge from internal medical department,
from two Medical Centres in Israel; EMMS Nazareth-
The Nazareth Hospital, and in Haemek Medical Center
in Afula, after its approval by the ethical committees of
both hospitals and after obtaining signed written
i n f o r m e dc o n s e n ta tt h es t u d ye n r o l l m e n tf r o ma l l
participants.
A sample of 74 patients were recruited for the study,
which formed two separate groups: an intervention
group, where patients, prior to discharge, received nurse
counseling and afterwards pharmacist interventions,
which took an average time of 20-30 minutes and a
control group, who had received the routine discharge
program that was provided by the hospital and dis-
c h a r g ec o u n s e l i n go n l yb yan u r s e .T h e s ep a t i e n t sw e r e
taken for data collection over a period of one year (from
Jan. 2010 to Jan. 2011). There was no restriction of sex,
marital status, educational level, ethnic group, socioeco-
nomic status and place of residence. Exclusion criteria
was illiterate patients, severely hearing impaired or
demented, patients not prescribed chronic medications
before hospitalization, patients with a coexisting term-
inal illness such as cancer or chronic renal failure
requiring dialysis, patients who were to be discharged to
another health-care facility, patients who were not able
to take their medication independently, and who didn’t
have assistance from a relative or a home care giver and
pregnant women. Patients who were discharged from
Nazareth Hospital and from Haemek Medical Center
and who followed the inclusion criteria were enrolled
into the intervention group. The control group was
determined using a history list of previously discharged
patients from these two medical centers and who fol-
lowed the inclusion criteria. All information regarding
age, sex, number of chronic medications they take were
obtained using Clalits’ health services “Ofek” computer
program.
Basic demographic information along with complete
medical history, type of treatment and the different rea-
sons for non-adherence were recorded. A senior physi-
cian interviewed the patients using a questionnaire that
was designed for this purpose. The pharmacist empha-
sized the importance of adherence and what to do if a
dose was missed. She/he also emphasized the impor-
tance of contacting the physician whenever feeling any
unusual change in overall health. By the end of the
counseling the pharmacist asked the patient about dis-
crepancies between her/his and the nurse’sc o u n s e l i n g .
When there were any, the nurse was called and reconci-
liation was made at the moment. The pharmacist used
the Thompson Micromedex
® healthcare series for get-
ting all the necessary and desired information regarding
her/his counseling. The correlation between medication
complexity and the parameters of age, gender, underly-
ing disorder and the number of medications were deter-
mined using the Medication regimen complexity index
(MRCI), which comprises three sections:
(1) Nature of dosing forms, that is, whether it is a
tablet/inhaler/gel.
(2) Dosing frequency, that is, how often the medica-
tion is taken.
(3) Additional directions that need to be followed, that
is, take before or after a meal/at a specific time/breaking
the tablet in half.
All entries on the MRCI were based on information
from our 74 participants’ scripts reviewed. If a script
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completed for each different medication. The MRCI is
an open-ended index, thus there would be no limit to
the total number of medications that could be included
on the MRCI. Data was analyzed using SPSS (Statistical
program for Social Sciences version 15.1). Chi-square
tests were used to compare gender, age, underlying con-
ditions and the number of medications.
Data collection
Each month, the research pharmacist looked for data
regarding each patient’s prescriptions filling by using the
information registered in a Clalits’ health services “Ofek”
computer program. The researcher checked the
following:
1. Whether the patient filled the prescription each
month regularly. Dates of prescription fillings were
registered.
2. When there were changes in two medications or
more the participant was followed tightly and extensive
clarification and explanation was provided to him/her to
insure full understanding of the medical regime changes
to avoid confusions. When there was a replacement of a
drug with another of the same therapeutic group, the
follow up was made to the new drug.
3. The researcher measured the intervals between
refills and compared the value to the days’ supply of
medication dispensed.
Furthermore, readmissions for both group patients
were monitored for the period of 6 months, and hospi-
talization costs were calculated using a list of hospitali-
zation costs in internal departments and intensive care
units. The dependent variables measured were: The
number of chronic medications, medication compliance
and the number of readmissions. Other dependent vari-
ables such as complexity of medication regimen, socioe-
conomic situation, including income and education level
were evaluated.
Adherence assessment
Monthly, each patient’s prescription filling was moni-
tored through a Clalit “Ofek” computerized program
which recorded all health information regarding
patients. It also included pharmacy prescription fillings.
The sum of the days’ supply obtained over a series of 6
months was calculated for each medication and was
divided by the total days from the beginning to end of
the time period (Table 1). This ratio is named Medica-
tion Possession Ratio (MPR).
Then his adherence would be:
(3 0+3 0+3 0 )

Totaldays
  supplyobtained

(3 0+3 0+9 0 )

Totaldays
  in3intervals
 =0 . 6 ∗100 = 60%
An MPR of 80% is a reasonable threshold for adher-
ence because it suggests very few days without drug on
hand and, consequently, fairly continuous medication
usage [20]. Values greater than 80% were categorized as
good adherence and values less than it, were categorized
as non-adherence. A mean adherence for each patient
and for each group was calculated for further analysis.
Readmissions assessment
Each patient was monitored for hospital readmissions;
we reviewed the medical record for each patient in
order to confirm the admission date and reason. Each
patient’s total days of hospitalization were documented.
Total number of readmissions was calculated. A com-
parison was made between the two groups to assess the
differences.
Study variables
The dependent variables were:
1. Medication adherence, which is dependent on the
pharmacist counseling, and on other variables such as
age, sex and complexity of medication regimen. Other
variables that may affect the medication adherence
which was not taken into consideration due to difficulty
obtaining such information by using the “Ofek” compu-
ter program are status of education, and socioeconomic
status.
The variable was calculated according to the equation
that was mentioned in the literature review.
2. Number of readmissions, which is dependent on
medication adherence.
The variable was obtained by using Clalits’ health ser-
vices “Ofek” computer program: each month we looked
for registered readmissions in different hospitals in
Israel.
The independent variables were:
1. Complexity of medication regimen.
2. Socioeconomic situation, including income
3. Education level
4. Pharmacist counseling
5. Number of chronic medications
6. Age
7. Sex
Table 1 Gives the example if a patient for a period of 3
months has taken the following days’ supply
Prescription
interval
Day of
fill
Days’ supply
obtained
Days in
interval
1 0 30 30
23 0 3 0 3 0
36 0 3 0 9 0
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a. Lost to follow up patients.
This bias can be dealt with by using the intention to
treat analysis.
Statistical analysis
For the statistical analysis the SPSS 14.0 software was
used, the statistical significance was set at bilateral 5%,
in addition, patient characteristics and responses were
summarized with descriptive statistics including fre-
quency, mean, SD, and range. Responses on the measure
of medication adherence were dichotomized as “compli-
ant” and “non-compliant.” A stepwise regression was
conducted in order to check the first hypothesis: as the
1
st step, the independent variable of pharmacist counsel-
ing was inserted into regression, followed by the other
variables: medication regimen complexity, age and sex
variables. A stepwise regression was conducted in order
to check the second hypothesis: as the 1st step the
dependent variable of medication adherence was
inserted, followed by the complexity of the medication
regimen, age and sex variables. Crosstabs were built and
relations between medication adherence variable and the
age, sex, number of readmissions and complexity of
medication regimen were obtained. Complexity of the
medication regimen for outpatients was assessed using
the Medication regimen complexity index (MRCI), a
tool used to assess medication complexity developed by
George et al. [28].
Results
In this descriptive study performed in the two medical
centers 74 patients were included (33 intervention
group and 41 control group). Mean age of intervention
group was (65.3 ± 12.17), were males represent 22 (67%)
and females form 11(33%). The number of chronic med-
ication was [(7 ± 2.7), (range: 3-17)], number of read-
missions [(0.7 ± 1.18), (range: 0-5)]. The adherence
percentage was [(77.83 ± 22.85), (range: 22.22-105.1)].
The control characteristics were as follow: mean age ±
SD [(72.73 ± 10.64), range (36-90)], were males repre-
sent 28 (68%) and females 13(32%). The number of
chronic medication was [(6.59 ± 1.9), (range: 3-11)]. The
number of readmissions was [(0.93 ± 1.01), (range: 0-3)].
The adherence percentage was [(62.46 ± 24.5), (range:
6.25-100)], (Table 2).
By dividing patients according to gender, number of
chronic medications, medication adherence, number of
readmissions as shown in (Table 3), the distribution of
variables among males (n = 50), were as follow: number
of chronic medications was (6.66 ± 2.43), medication
adherence was (69.20 ± 26.83) and number of readmis-
sions was (0.88 ± 1.02). The distribution of variables
among females (n = 24) was as follow: Number of
chronic medications was (7 ± 2.02), medication adher-
ence was (69.54 ± 20.66) and number of readmissions
was (0.71 ± 1.23).
Comparing the variables between both genders there
were no statistical significant differences. Table 4 sum-
marizes the distribution of age, number of chronic med-
ications, medication adherence, and number of
readmissions, in both the intervention and control
groups, the results was also statistically insignificant.
Conducting regression analysis for examining the first
hypothesis: “We assumed that patients with Heart Fail-
ure who had pharmacist counseling will have better
medication adherence than patients who had merely
nurse counseling,” while taking into consideration the
Table 2 Characteristics of the Intervention group (n = 33) and of the Control group (n = 41)
Characteristics Intervention group values Control group values
Age
Mean ± SD 65.3 ± 12.17 72.73 ± 10.64
Range 41.92 36-90
Sex
Male 22 (66.7%) 28 (68.3%)
Females 11 (33.3) 13 (31.7%)
Number of chronic medications
Mean ± SD 7 ± 2.71 6.59 ± 1.92
Range 3-17 3-11
Number of readmissions
Mean ± SD 0.7 ± 1.18 0.93 ± 1.01
Range 0-5 0-3
Adherence percentage
Mean ± SD 77.83 ± 22.85 62.46 ± 24.52
Range 22.22-105.10 6.25-100
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tion regimen (e.g. number of chronic medications each
patient have), their age and their sex. We found after
analyzing the regression, that having a pharmacist coun-
seling in the intervention group explains 11.6% of the
variance in medication adherence, [F change (1,73) =
9.43, p < 0.003], in comparison with the control group.
We can also notice that this variance that is explained
by the medication adherence is correlated to the phar-
macist counseling while the complexity of the medica-
tion regimen, the age of the patient and the sex don’t
contribute to the ability of predicting this variance
(Tables 5 and 6). Examining the second hypothesis (if
we have better medication adherence; this hypothesis
leads to less readmissions), while also taking into con-
sideration the effect of the differences in medication
regimen complexity, age and sex. Table 7 represents the
results of stepwise regression after inserting the four
independent variables which they predict readmissions.
By analyzing the stepwise regression, it is noticed that
the relation between medication adherence and readmis-
sions is not statistically significant [F (1,73) = 9.43, n.s].
None of the other variables can explain the variance in
the number of readmissions (Table 6).
Conclusions
Plethora of studies has confi r m e dt h a tt h er a t eo fn o n -
adherence is higher in patients with chronic illnesses
worldwide [29,30]. It is universally accepted that 50% to
75% of patients are non-adherent [31], which under-
mines their care and leads to increased health care costs
[32], morbidity, and mortality [33]. This is partially
because the drug regimens for these patients are often
long-term, complex thus altering existing behavioral pat-
terns. The World Health Organization has estimated
that, even in affluent countries with well-developed
health care infrastructure, adherence to long-term medi-
cation therapy for chronic illness averages only 50%
[34].
We have conducted a study whose aims were directed
toward increasing patients’ medication adherence and as
a result, decreasing their number of readmissions
through pharmacist-directed patient education (Table
2). This study focused specifically on patients with heart
failure who, according to the literature, are at higher
risk for early readmissions [35].
In our study we aimed to examine the role of the
pharmacists as healthcare professionals who can
improve adherence enhancement, since a few studies
have been conducted on checking the contribution of
pharmacist medication counseling to patients when dis-
charged from hospitals. We found that pharmacists can
play a quintessential role in initiating such an education
to patients and in monitoring their adherence in order
to improve their treatment outcomes. Education and
counseling regarding medication therapy given to
Table 3 Shows the distribution of variables in both gender
Age Number of chronic medications Medication adherence Number of readmission
Males N = 50
Mean ± SD 76.9 ± 12.27 6.66 ± 2.43 69.20 ± 26.83 0.88 ± 1.02
Minimum 36 3 6.25 0
Maximum 90 17 100 3
Females N = 24
Mean ± SD 72.6 ± 10.49 7 ± 2.02 69.54 ± 20.66 0.71 ± 1.23
Minimum 52 4 24.98 0
Maximum 92 11 105.1 5
1 For the statistical analysis (Chi-squared test) using SPSS 14.0 software was performed
2 The statistical significance level that was used was bilateral 5%
Table 4 Summarizes the distribution of variables in both the intervention and control groups
Age Number of chronic medications Medication adherence Number of readmission
Intervention group N = 33
Mean ± SD 65.33 ± 12.12 7 ± 2.71 77.83 ± 22.85 0.7 ± 1.18
Minimum 41 3 22.22 0
Maximum 92 17 105.10 5
Control group N = 41
Mean ± SD 72.73 ± 10.64 6.59 ± 1.92 62.45 ± 24.52 0.93 ± 1.01
Minimum 36 3 6.25 0
Maximum 90 11 100 3
1 For the statistical analysis (Chi-squared test) using SPSS 14.0 software was performed
2 The statistical significance level that was used was bilateral 5%
Bisharat et al. Journal of Translational Medicine 2012, 10:34
http://www.translational-medicine.com/content/10/1/34
Page 6 of 9patients at discharge has been shown to affect demand
and utilization of health services along several
dimensions.
Indeed, we support the idea that incorporating a phar-
macist as part of the health providing team, especially in
hospitals, is crucial and contribute to both improving
patients’ health and reducing the burden over the health
system. Moreover, our pharmacist interventions
explained 11.6% of the variance in patients’ medication
compliance in the intervention group in comparison to
the control group (p = 0.03).
Our research is in accordance with other opinions of
the indisputable fact that non-adherence is a serious
medical issue that may lead to death and elevated costs,
both for patients and providers and it is hard to identify
just one intervention for non-adherence because non-
adherence is different in all patients. Thus, no single
strategy appears to be the best, due to the multitude of
factors that affect a patient’s decision to adhere to the
prescribed medications. In fact, adherence with medica-
tion is a challenge that faces the whole population
whether they are patients, medical professionals or both.
Concomitantly, we never lost hope to look for an
alternative strategies that might enhance the adherence
and decreases the readmissions through pharmacist-
directed patient education. We assume the motivation is
something that we can control. However, motivation is
internal. All we can do is educate an individual and sup-
port them to be motivated. In fact, remove barriers to
adherence, and increasing confidence, communication
between doctor and patient and trying to explain the
regimen complexity may help to improve the outcome
[36,37]. Furthermore, researchers suggest that pharma-
cists, having direct contact with patients while patients
are engaged in their medical regimen, have a better abil-
ity to detect adherence problems. A new stream that is
being proposed to improve patient adherence is to
implement a system around the community-based
pharmacist. A community-based pharmacist is one who
has direct involvement in a patient’s treatment plan, has
direct and frequent contact with physicians, and has an
active role in changing or altering a patient’s medical
regimen [38].
After studying the literature, one can only conclude
that there is still no real consensus concerning the
most effective way to improve patient adherence. The
research shows that adherence to medications are not
routinely measured in clinical practice and that a uni-
versal standard that can be easily implemented has
not been established [39-49]. Our study results are in
harmony with previous studies in emphasis the role of
the pharmacists in CHD patients’ management [27].
This synchronization spring up by the pharmacist
counseling contribution via increasing the patient edu-
cation and knowledge concerning their medication
adherence.
Study limitations
1. The Medication Possession Ration (MPR) method for
calculating each patient’s adherence may not be comple-
tely conveying the true situation. Early refilling would
lead to an MPR of more than 100%. In such case, the
MPR is often truncated at the maximum value of 100%
indicating the potential for perfect adherence. Moreover,
f o rs o m em e d i c a t i o n ,t h eM P Rv a l u em i g h tb em o r e
than 100%, reflecting inappropriate medication adher-
ence, and when calculating a mean MPR, this might
shift the whole value towards high medication adher-
ence when in fact the patient was not adherent in other
medications.
Moreover, although the MPR provides an insight into
the availability of medications, it doesn’t provide infor-
mation on the timeliness and consistency of refilling.
Table 5 Describes the results of a stepwise regression
after inserting of all variables
Variables r
Pharmacist Intervention 0.34***
Number of chronic medications 0.034 -
Age 0.052 -
Sex 0.062 -
Table 6 Compares the variance in medication adherence after having a pharmacist in the intervention group versus
the control group
Step Predicting
variable
R
2
Change
R2 F Change F t b
1 Pharmacist counseling 0.116 0.116 9.43 *** 9.43*** 3.071*** 0.37 ***
*** p < 0.05 n = 74
Table 7 Represents the results of stepwise regression
analysis after inserting the independent variables
Variables r
Pharmacist counseling 0.141 -
Number of chronic medications 0.131
Age 0.054
Sex 0.074 -
By analyzing the stepwise regression, it is noticed that the relation between
medication adherence and readmissions is not statistically significant [F (1,73) =
9.43, n.s]. None of the other variables can explain the variance in the number
of readmissions
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be small and insignificant.
2. It is assumed that a new refill of a prescription
implies complete ingestion of the previous refill. How-
ever, the possibility exists that an individual may be pro-
viding mediations to others, dumping medications before
refilling, or stockpiling medications for future usage.
3 The selection of a cut-off value directly affects the
measurement’s accuracy of providing information on the
continuity of medication usage.
4 .T h es a m p l es i z em a yb et o os m a l li no r d e rt o
obtain more statistically significant results.
Strengths of the study
Medication adherence among patients in Israel is very
low, especially among Cardiac patients. Defining a prac-
tical education method will help increase the knowledge
of each patient regarding the medication he or she
takes, and thus improves their medication adherence.
This will help patients to benefit from their medical
regimen which will lead to a decrease in the rate of
readmissions.
Pharmacist counseling of Cardiac patients prior to dis-
charge from internal departments can improve medica-
tion adherence by improving their knowledge, and can
contribute to improving the effectiveness and benefit
from medical treatments, and thus reducing costs
accompanied to readmissions.
In summary, medication adherence is an important
persistent problem and certain interventions could be
effective in improving medication use after discharge.
Pharmacists are the critical piece for elevating the dis-
cussion of medication adherence–with both other
medical professionals and directly with patients. These
highly trained professionals are among the nation’s
most respected professional and among the most
accessible to consumers. Solutions should not only
help design scientifically-based, proven intervention
strategies, but also reduce the time and cost involved
with implementing these strategies in various health-
care settings.
Behavior change requires different strategies for differ-
ent people. Trust, hope, fear, motivation, knowledge, lit-
eracy, skills, tools, rehearsal, reinforcement, feedback,
confidence and competence are key concepts in the lit-
erature of medication adherence. The problem of non-
adherence often defies isolated efforts and tactics, but
studies have shown that multi-disciplinary approaches
work well, multiple channels work better than single
channels, and a longer time horizon is more realistic
than a short one. Indeed everyone is different, and
everyone changes over time.
Acknowledgements
This study was funded by: The Israel National Institute for Health Policy and
Health Services Research. Tel-Hashomer 52621, Israel. Phone: +972-3-
5303516/7, Fax: +972-3-5303250, http://nihp@israelhpr.health.gov.il.
Author details
1Department of Internal Medicine and Clinical Neuroscience, EMMS
Nazareth-The Nazareth Hospital, Nazareth 16100, Israel.
2School of Public
Health Haifa University, Haifa, Israel.
Authors’ contributions
BB - carried out the study design and participating in the recruitment of
patients in addition participated in editing the manuscript and finding the
manuscript. LH - Participated in the study design, and performed the tables
and figures and helped in performing the statistical analysis. OB -
participated in the collections of data and study design, editing the
manuscript and participated in writing part of the introduction. ZH -
Participated in writing part of the conclusion and study design, editing the
manuscript, and in helped to draft the manuscript. BA - Conceived the
study, and participated in its design and coordination and wrote almost all
manuscript (introduction & discussion) and helped to draft the manuscript.
All coauthors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 November 2011 Accepted: 1 March 2012
Published: 1 March 2012
References
1. Russell S, Daly J, Hughes E, op’t-Hoog C: Nurses and ‘difficult’ patients:
negotiating non-adherence. JAN 2003, 43:281-287.
2. Amaral P: The special case of compliance in the elderly. In Compliance:
the dilemma of the chronically ill. Edited by: Gerber K, Nehemkis A. New
York: Springer; 1986:.
3. World Health Organization: Adherence to long-term therapies: evidence
for action. 2003, Available from: [http://apps.who.int/medicinedocs/en/d/
Js4883e/5.html] (last accessed 18th April 2010).
4. , Frost & Sullivan’s. 6th Annual Patient Adherence Congress March 10, 2011,
the Union League, Philadelphia, PA. [http://www.frost.com].
5. Cabezas C, Salvador C, Quadrada D, Bartes A, Bore M, Perea N, Peipoch E:
Randomized clinical trial of a post-discharge pharmaceutical care
program vs. regular follow-up in patients with heart failure. Farm Hosp
2006, 30:328-342.
6. Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC: Factors associated
with exacerbation of heart failure include treatment adherence and
health literacy skills. Clin Pharmacol Therapeut 2009, 85:651-658.
7. Sadik A, Yousif M, McElnay J: Pharmaceutical care of patients with heart
failure. Br J Clin Pharmacol 2005, 60:183-193.
8. Urquhart J: Some economic consequences of nonadherance. Curr
Hypertens Rep 2001, 3:473-480.
9. Wu J, Moser D, Chung M, Lennie T: Objectively measured, but not self-
reported, medication adherence independently predicts event-free
survival in patients with heart failure. J Card Fail 2008, 14:203-210.
10. Kerzman H, Baron-Epel O, Toren O: What do discharged patients know
about their medication? Patient Educ Couns 2004, 2004(56):276-282.
11. Jin J, Sklar GE, Sen-Oh VM, Chuen-Li S: Factors affecting therapeutic
adherance: a review from the patient’s perspective. The Clin Risk Manag
2008, 4:269-286.
12. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl J,
Wu AW: Self-reported adherence to antiretroviral medications among
participants in HIV clinical trials: the AACTG adherence instruments. AIDS
Care 2000, 12:255-266.
13. Dilorio C, Yeager K, Shafer PO, Letz R, Henry T, Schomer DL, McCarty F: The
epilepsy medication and treatment complexity index: reliability and
validity testing. J Neurosci Nurs 2003, 35:155-162.
14. Dilorio C, Faherty B, Manteuffel B: Cognitive-perceptual factors associated
with antiepileptic medication compliance. Res Nurs Health 1991,
14:329-338.
Bisharat et al. Journal of Translational Medicine 2012, 10:34
http://www.translational-medicine.com/content/10/1/34
Page 8 of 915. Graveley EA, Oseasohn CS: Multiple drug regimens: medication
compliance among veterans 65 years and older. Res Nurs Health 1991,
14:51-58.
16. Andrade SE: Discontinuation of antihyperlipidemic drugs. Do rates
reported in clinical trials reflect rates in primary care settings? N Engl J
Med 1995, 332:1125-1131.
17. Bloom BS: Continuation of initial antihypertensive medication after 1
year of therapy. Clin Ther 1998, 20:671-681.
18. Sidel J: Shaping the healthcare environment through evidence based
medicine: a case study of the ICONS project. Hosp Quart 1998, 2:29-33.
19. Sullivan SD, Kreiling DH, Hazlet TK: Nonadherance with medication
regimens and subsequent hospitalizations: literature analysis and cost of
hospitalization estimate. J Res Pharm Econ 1990, 2:19-33.
20. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a
self-reported measure of medication adherence. Medical Care 1986,
24:67-74.
21. McLean W: An adherence study of prescription refill data, with and
without a periodic patient education program. Car Pharm J 2007,
140:104-106.
22. Rosenstock IM: Historical origins of the health belief model. Health Educ
Monogr 1974, 2:328-335.
23. Chabot I, Moisan J, Gregoire JP, Milot A: A pharmacist intervention
program for control of hypertension. Ann Pharmacother 2003,
37:1186-1193.
24. Côte I, Gregoire JP, Moisan JA: A pharmacy-based health promotion
program in hypertension: cost-benefit analysis. PharmacoEconomics 2003,
21:415-428.
25. Galt KA: Cost avoidance, acceptance and outcomes associated with a
pharmacotherapy consult clinic in a veteran’s affairs medical center.
Pharmacotherapy 1998, 18:1103-1111.
26. Munroe WP, Kunz K, Dalmady-Israel C: Economic evaluation of pharmacist
involvement in disease management in a community pharmacy setting.
Clin Ther 1997, 19:113-123.
27. Poston J: The medication use study: a large-scale controlled evaluation
of the effects of the vital interests program on adherence to medication
regimens. Can Pharm J 1999, 123:31-38.
28. George J, Phun YT, Bailey MJ, Kong DC, Stewart K: Development and
validation of the medication regimen complexity index. Ann
Pharmacother 2004, 38:1369-1376.
29. Berk M, Berk L: Mood stabilizers and treatment adherence in bipolar
disorder: addressing adverse events. Ann Clin Psychiatry 2003, 15:217-224.
30. Adherance:, The Merck Manual of Diagnosis and Therapy, section 19,
Chapter 258, Drug Treatment in Newborns, Infants, and Children. Available
at www.merck.com.
31. Jones G: Prescribing and taking medicines. BMJ 2003, 327:819-820.
32. Morris LS, Schulz RM: Patient adherence–an overview. J Clin Pharm Ther
1992, 17:283-295.
33. McDonald HP, Garg AX, Haynes RB: Interventions to enhance patient
adherence to medication prescriptions. JAMA 2002, 288:2868-2879.
34. World Health Organization: Adherence to Long-Term Therapies: evidence for
Action Geneva: World Health Organization; 2003.
35. Calabrese A, Cholka K, Lenhart S, McCarty B, Zewe G, Sunseri D, Roberts M,
Kapoor W: Pharmacist involvement in a multidisciplinary inpatient
medication education program. Am J Health-Syst Pharm 2003,
60:1012-1018.
36. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shelvin M: Medication
adherance: a healthcare problem. Ann Pharmacother 1993, 27:5-19.
37. Greenburg RN: Overview of patient adherence with medication dosing: a
literature review. Clin Ther 1984, 6:591-599.
38. Sipkoff M: The newsletter of quality issues in health care. Quality Indicator
2001.
39. Dunbar-Jacob J, Mortimer-Stephens MK: Treatment adherence in chronic
disease. J Clin Epidemiol 2001, 54:57-60.
40. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R:
Interventions for helping patients to follow prescriptions for
medications. Cochrane Database Syst Rev 2000, 2:CD000011.
41. Roter DL, Hall JA, Merisca B, Nordstrom D, Cretin B: Effectiveness of
interventions to improve patient adherence: a meta-analysis. Med Care
1998, 36:1138-1161.
42. Ellis S, Shumaker S, Sieber W, Rand C: Adherence to pharmacological
interventions: current trends and future directions. Control Clin Trials
2000, 21:218-225.
43. Jackevicius CA, Mamdani M, Tu JV: Adherence with statin therapy in
elderly patients with and without acute coronary syndromes. JAMA 2002,
288:462-467.
44. Benner JS, Glynn RJ, Neumann PJ, Mogun H, Weinsten MC, Avorn J: Long-
term persistence in use of statin therapy in elderly patients. JAMA 2002,
288:455-461.
45. Haynes RB: Improving patient adherence. In State of the art, with a special
focus on medication taking for cardiovascular diseases. Edited by: Burke LE,
Ockene IS. Armonk: Adherance in Healthcare and Research. Futura
Publishing; 2001:.
46. Volmink J, Garner P: Systematic review of randomized controlled trials of
strategies to promote adherence to tuberculosis treatment. BMJ 1997,
315:1403-1406.
47. Farmer KC: Methods for measuring and monitoring medication regimen
adherence in clinical trials and clinical practice. Clin Ther 1999,
21:1074-1090.
48. Turner BJ, Hecht FM: Improving on a coin toss to predict patient
adherence to medications. Ann Intern Med 2001, 134:1004-1006.
49. Vitolins MZ, Rand CS, Rapp SR, Ribisi PM, Sevick MA: Measuring adherence
to behavioral and medical interventions. Control Clin Trials 2000,
21:188-194.
doi:10.1186/1479-5876-10-34
Cite this article as: Bisharat et al.: Pharmacist counseling to cardiac
patients in Israel prior to discharge from hospital contribute to
increasing patient’s medication adherence closing gaps and improving
outcomes. Journal of Translational Medicine 2012 10:34.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bisharat et al. Journal of Translational Medicine 2012, 10:34
http://www.translational-medicine.com/content/10/1/34
Page 9 of 9